Birner Hubert

Director at Horizon Therapeutics Public Ltd Co · on record since Jul 28, 2011
10% owner at ENANTA PHARMACEUTICALS INC · on record since Mar 28, 2013
10% owner at BLUE MARTINI SOFTWARE INC · on record since Jun 24, 2013
10% owner at CONCERT PHARMACEUTICALS, INC. · on record since Feb 20, 2014
Director at ARGOS THERAPEUTICS INC · on record since Feb 12, 2014
10% owner at ARGOS THERAPEUTICS INC · on record since Feb 12, 2014
Director at Protara Therapeutics, Inc. · on record since Oct 30, 2014
10% owner at Protara Therapeutics, Inc. · on record since Oct 30, 2014
Director at Acer Therapeutics Inc. · on record since Sep 27, 2017
10% owner at Acer Therapeutics Inc. · on record since Sep 27, 2017

Insider trading activity of Birner Hubert

Transactions on record: 64; since Aug 4, 2011

Open-market buys: 7; $4.7M

Open-market sells: 6; $9M

Companies traded: 4; last filing Jun 11, 2018

Figures computed from official regulatory filings — .

Companies where Birner Hubert has traded

Protara Therapeutics, Inc.24 tx · $3.7M · Jun 11, 2018
ARGOS THERAPEUTICS INC20 tx · $319K · Jan 20, 2017
ENANTA PHARMACEUTICALS INC6 tx · $9M · Feb 27, 2014
Horizon Therapeutics Public Ltd Co14 tx · $2.5M · Aug 4, 2011

Track record of Birner Hubert

Statistical track record

Free

Open-market buys: 9

Last buy: Jun 29, 2016

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Birner Hubert

Co-insiders of Birner Hubert

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Protara Therapeutics, Inc.Listing on record	Jun 11, 2018	AwardD (derivative)	12,700	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 21, 2017	AwardD (derivative)	6,666	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jan 20, 2017	AwardD (derivative)	9,500	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jan 4, 2017	Award	3,571	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Oct 3, 2016	Award	3,521	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 5, 2016	Award	2,854	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 1, 2016	BuyD (derivative)	206,659	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 1, 2016	Buy	275,545	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 15, 2016	AwardD (derivative)	6,666	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jun 14, 2016	AwardD (derivative)	5,500	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Apr 4, 2016	Award	2,734	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Mar 16, 2016	Buy	183,697	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Mar 16, 2016	BuyD (derivative)	137,773	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jun 19, 2015	AwardD (derivative)	5,500	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 3, 2015	AwardD (derivative)	6,666	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-451,276	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-2,436,618	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Buy	223,410	10.00 USD	$2.2M	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-717,260	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Buy	76,590	10.00 USD	$765.9K	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-1,531,518	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Other	379,462	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-799,043	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Other	39,932	4.60 USD	$183.7K	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-39,932	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Protara Therapeutics, Inc.Listing on record	Jun 11, 2018	AwardD (derivative)	12,700	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 21, 2017	AwardD (derivative)	6,666	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jan 20, 2017	AwardD (derivative)	9,500	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jan 4, 2017	Award	3,571	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Oct 3, 2016	Award	3,521	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 5, 2016	Award	2,854	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 1, 2016	BuyD (derivative)	206,659	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jul 1, 2016	Buy	275,545	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 15, 2016	AwardD (derivative)	6,666	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jun 14, 2016	AwardD (derivative)	5,500	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Apr 4, 2016	Award	2,734	0.00 USD	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Mar 16, 2016	Buy	183,697	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Mar 16, 2016	BuyD (derivative)	137,773	—	—	SEC
ARGOS THERAPEUTICS INCListing unverified	Jun 19, 2015	AwardD (derivative)	5,500	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Jun 3, 2015	AwardD (derivative)	6,666	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-451,276	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-2,436,618	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Buy	223,410	10.00 USD	$2.2M	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-717,260	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Buy	76,590	10.00 USD	$765.9K	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-1,531,518	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Other	379,462	—	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-799,043	0.00 USD	—	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	Other	39,932	4.60 USD	$183.7K	SEC
Protara Therapeutics, Inc.Listing on record	Oct 30, 2014	OtherD (derivative)	-39,932	0.00 USD	—	SEC